End-to-End Technologies for Precision Liver Medicine
Data and genomic technologies powering our innovation

Technology

At Ophiomics, the power of bioinformatics, artificial intelligence, and genomics comes together to advance precision medicine for liver health. With end-to-end capabilities-from discovery to clinical deployment-we develop and own every aspect of our technology, enabling innovative, reliable solutions tailored for the full spectrum of liver disease care.

ophiomics_ai
Data and AI

All our end products incorporate machine learning models that enable us to extract more and better information from data, and to integrate diverse data types, such as clinical and biomarker-based data.

Know more
OMICs

In our quest to make precision medicine a reality, we developed re-usable Dx-oriented technological platforms (and some other simpler solutions) that enable and facilitate our development of new products and reduce the industrialisation and logistic uncertainties.

Know more
ophiomics_technology
market
R&D

New in vitro diagnostics medical devices are essential components of a precision medicine to improve early detection, diagnosis, and treatment, ultimately leading to better patient outcomes. We developed a unique approach to biomarker discovery and development centred around addressing unmet medical needs and minimising technical, clinical, and commercial uncertainties, enabling us to maximize the chances of bringing impactful products to market and positively impacting patients’ lives. 

Know more